Garrie Richardson - 19 Oct 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Revenue Officer
Signature
/s/ Garrie Richardson
Issuer symbol
BLFS
Transactions as of
19 Oct 2023
Net transactions value
$0
Form type
4
Filing time
01 Nov 2023, 17:29:41 UTC
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Award +36,320 +53% 105,327 19 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "Plan") and vests 25% on the first anniversary of the grant date and thereafter annually, in 4 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2023 compensation in connection with their appointment as Chief Revenue Officer.